Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D3022
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 754 $3,479,741 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $3,479,741 Current and potential, with all options
- Last date to order 9% complete
- IDV ceiling <1% used
- $9,999,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) valued at $9,999,999,999 to AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical and medical supply products to support military healthcare programs globally. The IDC has a period of performance through December 2036 and serves as a prime contracting vehicle for the DLA to procure essential medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. This unrestricted, fully competitive acquisition was awarded on a lowest price technically acceptable basis, with the intent to make multiple regional awards to ensure resiliency and access to vital pharmaceuticals during contingency operations. The scope of the contract encompasses worldwide pharmaceutical support to various DoD customers, the U.S. Coast Guard, and other government agencies, covering both normal day-to-day operations and planned/unplanned contingency requirements.
The original solicitation, expected to be issued in March 2024, will establish Pharmaceutical Prime Vendor Global Program Generation V contracts to replace the current DLA Troop Support Pharmaceutical Prime Vendor program. The $30.3 billion procurement will award multiple primary suppliers for regional line items (North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet) as well as a separate backup supplier. This diversified approach aims to mitigate supply chain risks and ensure the Department of Defense's ability to access essential pharmaceuticals during emergencies. The contract will utilize a firm-fixed price, requirements-type structure with a 30-month base period and three 30-month option periods.
Task orders
Show 40 more
Latest 50 of 754 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DR25D3022?
SPE2DR25D3022 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR25D3022 worth?
Orders under SPE2DR25D3022 have obligated $3,479,741. SPE2DR25D3022's own ceiling is $9,999,999,999.
How many orders have been placed under contract SPE2DR25D3022?
754 orders have been placed under SPE2DR25D3022, the latest on July 27, 2026.
Who can order from contract SPE2DR25D3022?
SPE2DR25D3022 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D3022 competed?
The extent of competition for SPE2DR25D3022 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV